Want to see HK:1931 full AI Analyst Report?
1931 Stock Chart & Stats
HK$3.85
HK$0.05(2.67%)
At close: 4:00 PM EST
HK$3.85
HK$0.05(2.67%)
Day’s Range― - ―
52-Week RangeHK$0.56 - HK$12.86
Previous CloseN/A
Volume18.00K
Average Volume (3M)1.48M
Market Cap
HK$940.46M
Enterprise ValueHK$2.33B
Total Cash (Recent Filing)HK$551.05M
Total Debt (Recent Filing)HK$1.93B
Price to Earnings (P/E)23.2
Beta0.54
Next Earnings
Aug 14, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.81%
Share Statistics
EPS (TTM)0.02
Shares Outstanding1,621,488,000
10 Day Avg. Volume1,443,300
30 Day Avg. Volume1,483,483
Financial Highlights & Ratios
PEG Ratio-1.25
Price to Book (P/B)1.29
Price to Sales (P/S)1.35
P/FCF Ratio-3.78
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Defensive Industry ExposureOperating in medical distribution provides structural demand durability; hospitals and clinics require recurring supplies and logistics services. That recurring demand and essential nature of products supports more stable revenue streams and underpins recovery prospects over the coming months.
Multi-year Operating Strength Pre-2025The company delivered healthy operating margins and positive growth from 2021–2024, indicating effective cost structures, customer relationships, and distribution capabilities. Those entrenched operational competencies increase the chance of restoring profitability as transient pressures abate.
Sizeable Equity Cushion And Prior Low LeverageA historically conservative balance sheet and a sizable equity base provide a structural buffer against shocks and give management room to access financing or restructure if needed. That prior capital strength supports medium-term strategic flexibility and resilience.
Bears Say
Revenue And Margin Collapse In 2025A sharp 2025 revenue decline and material margin compression represent a persistent earnings reset rather than a minor fluctuation. Reduced top-line and margin erosion weaken operating leverage, constrain reinvestment capacity, and can depress medium-term profitability absent clear signs of structural recovery.
Deeply Negative Operating And Free Cash FlowOperating cash flow swung deeply negative and free cash flow declined substantially, indicating working-capital stress or higher cash outlays. Sustained negative cash generation raises funding and liquidity risk, forcing reliance on external financing or asset sales that impair long-term stability.
Rising Leverage And Weakened ReturnsLeverage increased meaningfully in 2025 while returns collapsed, reducing financial flexibility and increasing borrowing costs risk. Higher debt and much lower ROE constrain capacity to invest in growth and make the business more vulnerable to cyclical or funding shocks over the medium term.
IVD Medical Holding Limited News
1931 FAQ
What was IVD Medical Holding Limited’s price range in the past 12 months?
IVD Medical Holding Limited lowest stock price was HK$0.56 and its highest was HK$12.86 in the past 12 months.
What is IVD Medical Holding Limited’s market cap?
IVD Medical Holding Limited’s market cap is HK$940.46M.
When is IVD Medical Holding Limited’s upcoming earnings report date?
IVD Medical Holding Limited’s upcoming earnings report date is Aug 14, 2026 which is in 5 days.
How were IVD Medical Holding Limited’s earnings last quarter?
IVD Medical Holding Limited released its earnings results on Mar 27, 2026. The company reported -HK$0.003 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.003.
Is IVD Medical Holding Limited overvalued?
According to Wall Street analysts IVD Medical Holding Limited’s price is currently Overvalued.
Does IVD Medical Holding Limited pay dividends?
IVD Medical Holding Limited pays a Notavailable dividend of HK$0.062 which represents an annual dividend yield of 3.81%. See more information on IVD Medical Holding Limited dividends here
What is IVD Medical Holding Limited’s EPS estimate?
IVD Medical Holding Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does IVD Medical Holding Limited have?
IVD Medical Holding Limited has 1,621,488,000 shares outstanding.
What happened to IVD Medical Holding Limited’s price movement after its last earnings report?
IVD Medical Holding Limited reported an EPS of -HK$0.003 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.893%.
Which hedge fund is a major shareholder of IVD Medical Holding Limited?
Currently, no hedge funds are holding shares in HK:1931
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
IVD Medical Holding Limited Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
320.00%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
12.45%
Trailing 12-Months
Company Description
IVD Medical Holding Limited
null
Technical Analysis
China Health Group
―
Shanghai Pharmaceuticals Holding Co
―
Sinopharm Group Co
―
Medlive Technology Co., Ltd.
―
Charmacy Pharmaceutical Co., Ltd. Class H
―